The CEO's sustained selling over a six-week window at prices near $600-$637 suggests a planned diversification or liquidity event rather than a change in conviction, as his percentage ownership remained stable. Monitor for any acceleration of sales or a change in the 19.1% threshold in future filings.
Price Chart
Executive Summary
August J. Troendle, CEO and founder of Medpace, filed Amendment No. 24 to his Schedule 13D, reporting a reduction in his beneficial ownership from 19.1% to 19.1% (unchanged percentage) via open-market sales of common stock between August 10 and September 25, 2026. The filing is a routine update reflecting insider selling activity with no change in stated purpose or demands.
Key Financial Metrics
Key Facts
- August J. Troendle sold shares of Medpace common stock in open-market transactions from August 10, 2026 to September 25, 2026.
- Troendle's beneficial ownership remains at 19.1% of common stock, unchanged from the prior filing.
- Medpace Investors, LLC (controlled by Troendle) holds 4,733,019 shares, representing 16.8% of common stock.
- Total shares beneficially owned by Troendle: 5,396,508 shares (including Medpace Investors, LLC holdings).
- No new demands, strategic review, or change in purpose disclosed in this amendment.
Financial Impact
Troendle sold shares across dozens of transactions at prices ranging from approximately $600 to $637 per share, with total proceeds estimated in the tens of millions of dollars based on disclosed share counts and price ranges.
Risk Factors
- Continued insider selling could signal management's view that the stock is fairly valued or that near-term upside is limited.
- No change in purpose or demands — the activist posture remains passive, reducing likelihood of near-term catalyst.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13D/A Filing (Primary) | 0001193125-26-405684 |
| Document: 0001193125-26-405684-index.html | 0001193125-26-405684 |
| Document: 0001193125-26-405684.txt | 0001193125-26-405684 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 2d ago | Institutional Cluster | $664.72 | awaiting T+1 | — | $676.21 (+1.73%) |
Oct 21, 2026 4d ago | 8-K | $653.96 $669.20 | ▲ +2.33% | ▲ +2.85% | $676.21 (+3.40%) |
Sep 28, 2026 27d ago | SC 13D/A | $622.11 $624.18 | ▲ +0.33% | ▲ +0.54% | $676.21 (+8.70%) |
Aug 31, 2026 7w ago | Insider Cluster | $583.21 $593.02 | ▲ +1.68% | ▲ +1.24% | $676.21 (+15.95%) |
Aug 28, 2026 8w ago | Insider Cluster | $593.99 $583.21 | ▼ −1.81% | ▼ −1.13% | $676.21 (+13.84%) |
Aug 27, 2026 8w ago | Insider Cluster | $600.65 $593.99 | ▼ −1.11% | ▼ −0.81% | $676.21 (+12.58%) |
Aug 25, 2026 8w ago | Insider Cluster | $619.05 $611.57 | ▲ +1.21% | ▲ +1.86% | $676.21 (−9.23%) |
Aug 24, 2026 8w ago | Insider Cluster | $614.06 $619.05 | ▲ +0.81% | ▲ +0.79% | $676.21 (+10.12%) |
Aug 21, 2026 9w ago | Insider Cluster | $620.03 $614.06 | ▼ −0.96% | ▼ −1.28% | $676.21 (+9.06%) |
Aug 19, 2026 9w ago | 144 | $608.27 $612.64 | ▲ +0.72% | ▲ +1.56% | $676.21 (+11.17%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers